Achieving a High Performance, Diverse Accrual, Clinical Tria

Achieving a High Performance, Diverse Accrual, Clinical Trial Program in an Academic Health System | Manatt, Phelps & Phillips, LLP

The United States occupies a leadership position in clinical advancements, in terms of pharmaceuticals, medical devices, innovative care processes and interventional techniques. At the...

Related Keywords

United States , American , Phelps Phillips , White House Office Of Science Technology , Veterans Administration , Us Veterans Affairs Website , Clinical Trial Program Performance , Biden Administration , Oncology Center , Research Administrative Services , Clinical Research Infrastructure , Interagency Group To Accelerate Trial Enrollment , Us Congress , Community Hospital Partnerships , Research Projects Agency For Health , National Institutes Of Health , Community Outreach , Henrietta Lacks Enhancing Cancer Research Act , Henrietta Lacks Enhancing Cancer Research , White House Office Of Science , Us Government Accountability Office , Clinical Trial Networks , Government Accountability Office , Public Health Emergency , Drug Administration , African American , Review Board , Hospital Partnerships , Clinical Trial , Some Questions , Assess Clinical Trial Program , Practice Culture , Administrative Services , Patient Engagement , Diverse Populations , Clinical Treatment Act , Improve Enrollment , Participants From Underrepresented Racial , Ethnic Populations , Project Equity , Health Emergency , National Institutes , Research Projects Agency , Interagency Group , Accelerate Trial Enrollment , White House Office , Science Technology , Emergency Clinical Trials , Cancer Clinical Trials , Federal Actions , Selected Non Federal Practices , Facilitate Diversity , Female Enrollment , Participant Sex , Trials Between , Older Adults , Clinical Trials , New Drug Applications , Biologics License Applications From , Diverse Clinical Trial Participation , Accessed August , Clinical Treatment , Consolidated Appropriations Act , Excellence Project Equity , Medical Products During , Institutional Review , Institutional Review Board , Technology Policy ,

© 2025 Vimarsana